Showing results (111-120 of 142) with videos related to
Sort By:
Pageof 15
European Journal of Nuclear Medicine and Molecular Imaging|September 28, 2013
Comparison of PET imaging with a (68)Ga-labelled PSMA ligand and (18)F-choline-based PET/CT for the diagnosis of recurrent prostate cancerAli Afshar-Oromieh, Christian M Zechmann, Anna Malcher, et al.Scientific Reports|May 10, 2018
Impact of 18F-FET PET on Target Volume Definition and Tumor Progression of Recurrent High Grade Glioma Treated with Carbon-Ion RadiotherapyCharlotte Debus, Maria Waltenberger, Ralf Floca, et al.European Journal of Nuclear Medicine and Molecular Imaging|December 1, 2023
Early response monitoring during [177Lu]Lu-PSMA I&T therapy with quantitated SPECT/CT predicts overall survival of mCRPC patients: subgroup analysis of a Swiss-wide prospective registry studyMoritz C Neubauer, Guillaume P Nicolas, Andreas Bauman, et al.Clinical Oral Investigations|April 11, 2025
Radioactivity levels in the saliva of patients undergoing targeted radioligand therapy with [177Lu]Lu-PSMA-I&T and [177Lu]Lu-DOTA-TOCChristian Schedeit, Nasir Gözlügöl, Radi Saiyed Alsheikh, et al.European Journal of Nuclear Medicine and Molecular Imaging|November 2, 2019
68Ga-PSMA-11 PET/CT in patients with recurrent prostate cancer-a modified protocol compared with the common protocolFabian Haupt, Lotte Dijkstra, Ian Alberts, et al.European Journal of Nuclear Medicine and Molecular Imaging|January 23, 2026
Prompt PSA changes as a prognostic marker for response to PSMA-radioligand therapyWolfram A Bosbach, Radi Saiyed Alsheikh, Nasir Gözlügöl, et al.Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|August 22, 2015
The Theranostic PSMA Ligand PSMA-617 in the Diagnosis of Prostate Cancer by PET/CT: Biodistribution in Humans, Radiation Dosimetry, and First Evaluation of Tumor LesionsAli Afshar-Oromieh, Henrik Hetzheim, Clemens Kratochwil, et al.Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|January 27, 2018
Intraindividual Comparison of 99mTc-Methylene Diphosphonate and Prostate-Specific Membrane Antigen Ligand 99mTc-MIP-1427 in Patients with Osseous Metastasized Prostate CancerHendrik Rathke, Ali Afshar-Oromieh, Frederik Lars Giesel, et al.European Journal of Nuclear Medicine and Molecular Imaging|January 4, 2022
First results on kinetic modelling and parametric imaging of dynamic 18F-FDG datasets from a long axial FOV PET scanner in oncological patientsHasan Sari, Clemens Mingels, Ian Alberts, et al.Frontiers in Nuclear Medicine|March 30, 2026
Conceptual proposal for LLM-generated FDG PET/CT follow-up reports in melanoma: a pilot study on model stability and blinded expert evaluationWolfram A Bosbach, Marie S Heide, Nasir Gözlügöl, et al.Pageof 15